| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |